Sanara MedTech Inc.

SMTI | NASDAQ

Price Alert Chart Builder DCF Calculator

$35.19

+$0.02 (+0.06%)

Sep 22, 2026, 10:40 AM ET · Market open

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Market Data

Market Cap $323.32M

Enterprise Value $356.43M

Beta 1.16

Average Volume 180.53K

Shares Outstanding (Diluted) 8.66M

Shares Change YoY 0.58%

Institutional Ownership 17.14%

Exchange NASDAQ

ISIN US79957L1008

Price Performance

Price Change 1M 1.9%

Price Change 3M 61.7%

Price Change 6M 115.2%

Price Change YTD 52.3%

Price Change 1Y 4.0%

Price Change 3Y 3.4%

Price Change 5Y 0.9%

1M CAGR (ann.) 3.1%

1Y CAGR (ann.) 1.5%

5Y CAGR (ann.) 1.3%

All-Time CAGR 6.5%

Valuation

PE Ratio -9.45

Forward PE 64.09

PEG Ratio 0.03

Forward PEG -0.05

PS Ratio 2.94

Forward PS 2.50

PB Ratio 40.70

P/FCF Ratio 71.79

P/Adj. FCF Ratio 80.81

P/OCF Ratio 53.29

EV/Sales 3.25

EV/EBIT 51.10

EV/EBITDA 37.68

EV/FCF 79.14

Earnings Yield -10.6%

FCF Yield 1.4%

Adj. FCF Yield 1.2%

Financial Health

Net Debt $31.06M

Total Debt $48.53M

Cash & Short-Term Investments $15.42M

Total Assets $69.15M

Current Ratio 2.58

Quick Ratio 2.30

Debt / Equity Ratio 6.11

Debt / EBITDA 5.13

Debt / FCF 10.78

OCF / Debt 0.12

Interest Coverage 1.42

Altman Z-Score 3.92

Piotroski F-Score 5

Margins & Profitability

Gross Profit Margin 91.3%

Operating Profit Margin 9.4%

EBITDA Margin 8.6%

Net Profit Margin -29.1%

FCF Margin 4.1%

Adj. FCF Margin 3.6%

SBC / Revenue 0.5%

SBC Impact (per share) -11.2%

Returns

Return on Assets -46.3%

Return on Equity -473.6%

Return on Invested Capital 18.0%

Return on Capital Employed 18.1%

Return on Tangible Assets -66.3%

Historical Growth (CAGR)

Revenue CAGR 3Y 22.6%

Revenue CAGR 5Y 40.0%

Revenue CAGR 10Y 39.4%

EPS CAGR 3Y -77.9%

EPS CAGR 5Y -26.0%

EPS CAGR 10Y -31.3%

FCF CAGR 3Y 805.8%

FCF CAGR 5Y 130.5%

FCF CAGR 10Y 7.2%

Analyst Forecasts

Analyst Rating Buy

Analyst Count 3

EPS Growth Next 3Y 41.5%

Revenue Growth Next 3Y 15.7%

Earnings Date Nov 10, 2026

EPS Estimate (next Q) $0.06

EPS Growth Est (next Q) -33.3%

Revenue Est (next Q) $29.67M

Revenue Growth Est (next Q) 12.7%

Fair Value Estimates

Graham Number N/A

Graham Upside N/A

Lynch Fair Value N/A

Lynch Upside N/A

Price Target $35

Price Target Upside -0.5%

Cash Flow

Operating Cash Flow $5.69M

Free Cash Flow $4.5M

Adj. Free Cash Flow $4M

FCF Per Share $0.52

OCF Per Share $0.66

OCF/S Ratio 5.2%

Income Statement

Revenue $109.81M

Gross Profit $100.29M

Operating Income $10.28M

EBITDA $9.46M

Net Income $-32.01M

EPS (Diluted) -$3.72

Revenue / Employee $1.02M

Profit / Employee $-296.43K

Employees 108